Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Mitochondria-dependent phase separation of disease-relevant proteins drives pathological features of age-related macular degeneration
Nilsa La Cunza, Li Xuan Tan, Thushara Thamban, Colin J. Germer, Gurugirijha Rathnasamy, Kimberly A. Toops, Aparna Lakkaraju
Nilsa La Cunza, Li Xuan Tan, Thushara Thamban, Colin J. Germer, Gurugirijha Rathnasamy, Kimberly A. Toops, Aparna Lakkaraju
View: Text | PDF
Research Article Ophthalmology

Mitochondria-dependent phase separation of disease-relevant proteins drives pathological features of age-related macular degeneration

  • Text
  • PDF
Abstract

Age-related macular degeneration (AMD) damages the retinal pigment epithelium (RPE), the tissue that safeguards photoreceptor health, leading to irreversible vision loss. Polymorphisms in cholesterol and complement genes are implicated in AMD, yet mechanisms linking risk variants to RPE injury remain unclear. We sought to determine how allelic variants in the apolipoprotein E cholesterol transporter modulate RPE homeostasis and function. Using live-cell imaging, we show that inefficient cholesterol transport by the AMD risk-associated ApoE2 increases RPE ceramide, leading to autophagic defects and complement-mediated mitochondrial damage. Mitochondrial injury drives redox state–sensitive cysteine-mediated phase separation of ApoE2, forming biomolecular condensates that could nucleate drusen. The protective ApoE4 isoform lacks these cysteines and is resistant to phase separation and condensate formation. In Abca–/– Stargardt macular degeneration mice, mitochondrial dysfunction induces liquid-liquid phase separation of p62/SQSTM1, a multifunctional protein that regulates autophagy. Drugs that decrease RPE cholesterol or ceramide prevent mitochondrial injury and phase separation in vitro and in vivo. In AMD donor RPE, mitochondrial fragmentation correlates with ApoE and p62 condensates. Our studies demonstrate that major AMD genetic and biological risk pathways converge upon RPE mitochondria, and identify mitochondrial stress-mediated protein phase separation as an important pathogenic mechanism and promising therapeutic target in AMD.

Authors

Nilsa La Cunza, Li Xuan Tan, Thushara Thamban, Colin J. Germer, Gurugirijha Rathnasamy, Kimberly A. Toops, Aparna Lakkaraju

×

Figure 1

ApoE isoform-specific differences in regulating RPE cholesterol transport and microtubule dynamics.

Options: View larger image (or click on image) Download as PowerPoint
ApoE isoform-specific differences in regulating RPE cholesterol transpor...
(A) Stills from live imaging of mCherry-tagged human ApoE2, ApoE3, or ApoE4 (top panel, red) in primary RPE cultures. Tracks of individual ApoE vesicles (lower panel). Color bar shows displacement of individual tracks from short (cooler colors) to long (warmer colors); range, 0.0 μm to 4.212 μm. (B) Percentage of total ApoE tracks with displacement > 0.8 μm in RPE expressing ApoE2, ApoE3, or ApoE4. Mean ± SEM, n >18 cells per condition from 3 independent experiments. **P < 0.005. (C) Endogenous cholesterol content in mock-transfected or ApoE2-, ApoE3-, or ApoE4-expressing RPE treated with A2E. Mean ± SEM from 3 independent experiments, 3 replicates/experiment. (D) Representative images and quantitation of acetylated tubulin (green) immunostaining in mock-transfected or ApoE2-, ApoE3-, or ApoE4-expressing RPE treated with or without A2E. Cell boundaries are demarcated by zonula occludens 1 (ZO-1) (white) and nuclei are labeled with DAPI (blue). Cells expressing mCherry-ApoE (red) are outlined in yellow. (E) Quantification of acetylated tubulin intensity in mCherry-expressing cells. Mean ± SEM, n = 10 cells/condition. (B, C, and E) One-way ANOVA with Bonferroni’s posttest. *P < 0.01, **P < 0.001, ****P < 0.0001. See also Supplemental Figure 1.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts